Neil F. McFarlane insider trades

Open-market stock purchases and sales by Neil F. McFarlane, President and CEO at Zevra Therapeutics, Inc, from SEC Form 4 filings since Aug 15, 2016.

Recent trades

DateStockTradeValue
Feb 9, 2026ZVRA Zevra Therapeutics, IncSold$125K
Feb 7, 2026ZVRA Zevra Therapeutics, IncBought (not open market)—
Feb 2, 2026ZVRA Zevra Therapeutics, IncSold$853K
Jan 31, 2026ZVRA Zevra Therapeutics, IncBought (not open market)—
Jan 29, 2026ZVRA Zevra Therapeutics, IncBought (not open market)—
Jan 29, 2026ZVRA Zevra Therapeutics, IncBought (not open market)—
Oct 10, 2025ZVRA Zevra Therapeutics, IncSold$211K
Oct 10, 2025ZVRA Zevra Therapeutics, IncBought (not open market)—

Companies traded

  • ZVRA Zevra Therapeutics, Inc: 5 sales, last Feb 9, 2026
  • COLL Collegium Pharmaceutical, Inc: other filings, last May 16, 2024
  • ADMS Adamas Pharmaceuticals Inc: other filings, last Nov 24, 2021
  • RTRX Retrophin, Inc: 7 sales, last May 16, 2019

Get free alerts when Neil F. McFarlane files a new trade →